BRIEF published on 08/01/2024 at 13:04, 2 years 1 month ago St-Georges Eco-Mining Corp. Announces Major Investment in H2SX Corp Private Placement Investment Due Diligence St-Georges Eco-Mining Hydrogen Technology
BRIEF published on 08/01/2024 at 13:04, 2 years 1 month ago St-Georges Eco-Mining Corp. annonce un investissement majeur dans H2SX Corp. Investissement Placement Privé St-Georges Éco-Minière Technologie De L'hydrogène Vérifications Nécessaires
BRIEF published on 08/01/2024 at 12:55, 2 years 1 month ago Reyna Silver Acquires Mineral Hill District and Updates Operations Exploration Reyna Silver Mineral Hill Gryphon Project CRD Mineralization
BRIEF published on 08/01/2024 at 12:55, 2 years 1 month ago Reyna Silver acquiert le district de Mineral Hill et met à jour ses opérations Exploration Reyna Argent Colline Minérale Projet Griffon Minéralisation CRD
BRIEF published on 08/01/2024 at 12:44, 2 years 1 month ago Thomas Pfaadt Appointed as New Chief Financial Officer of Vita 34 AG Chief Financial Officer Finance Management Board Vita 34 AG Thomas Pfaadt
BRIEF published on 08/01/2024 at 12:44, 2 years 1 month ago Thomas Pfaadt nommé nouveau directeur financier de Vita 34 AG Conseil D'administration Finance Vita 34 AG Directeur Financier Thomas Pfaadt
BRIEF published on 08/01/2024 at 12:35, 2 years 1 month ago Immunic, Inc. to Announce Financial Results for Q2 2024 and Provide Corporate Update Biotechnology Clinical Trials Webcast Immunic, Inc. Q2 Financial Results
BRIEF published on 08/01/2024 at 12:35, 2 years 1 month ago Immunic, Inc. annoncera ses résultats financiers pour le deuxième trimestre 2024 et fournira une mise à jour de l'entreprise Biotechnologie Immunic, Inc. Webdiffusion Essais Cliniques Résultats Financiers Du Deuxième Trimestre
BRIEF published on 08/01/2024 at 12:35, 2 years 1 month ago Moderna Reports Second Quarter 2024 Financial Results and Business Updates Financial Results Q2 2024 Moderna Vaccine MRNA
BRIEF published on 08/01/2024 at 12:35, 2 years 1 month ago Moderna publie ses résultats financiers et ses mises à jour pour le deuxième trimestre 2024 Résultats Financiers Moderne T2 2024 Vaccin ARNm
Published on 09/11/2026 at 17:00, 4 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 17:00, 4 hours ago Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan
Published on 09/11/2026 at 15:25, 5 hours 35 minutes ago Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 15:00, 6 hours ago Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 14:30, 6 hours 30 minutes ago AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value
Published on 09/11/2026 at 19:44, 1 hour 15 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 2 hours 45 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 18:00, 3 hours ago ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/11/2026 at 07:00, 14 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 14 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
